Themis Medicare Ltd Reports 6.22% YoY Revenue Growth in FY 2024-25, Despite API Business Headwinds

Themis Medicare Ltd has reported a 6.22% YoY increase in revenue for the financial year 2024-25, reaching Rs. 405.51 crores. The Formulations segment showed remarkable growth of over 20% YoY, driven by strategic product mix, increased brand productivity, and efficient allocation of on-field workforce. The Hospital Business grew by over 13% YoY, led by Critical and Intensive Care segments. The Trade Business also performed well, posting over 45% YoY growth in Q2. Despite pricing pressures in China and domestic players, the API business maintained resilience through cost efficiency, sourcing optimization, and structural realignment efforts. The company's EBITDA and PAT stood at Rs. 49.05 crores and Rs. 29.83 crores, respectively.